Surveillance for Primary Melanoma in Those at Highest Risk | Overview
We can improve patient outcomes by increasing the detection of melanomas by focussing on those at highest risk. Prof Graham Mann discusses results of a study that demonstrated how close surveillance of high-risk patients for primary melanoma is both effective and cost-effective.
Prof Graham Mann
Translational Researcher, Melanoma Institute Australia | Chair of the Research Committee, Melanoma Institute Australia | Chair, The University of Sydney Cancer Research Network | Co-Director, Centre for Cancer Research, The Westmead Institute for Medical Research